Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Infectious Disease
•
Neurology
•
Neuromuscular
Do patients on eculizumab or ravulizumab require repeat vaccination against meningococcal infection after a certain interval?
Answer from: at Academic Institution
Yes, CDC recommends a booster Men B vaccine 1 year after completion of series and then every 2-3 years thereafter, and booster Men C every 5 years.
Sign in or Register to read more
16983
Related Questions
How do you identify patients with false positive AcHR antibodies?
How does one interpret an SPEP showing potentially obscured but non-quantifiable M-spike however an IFE showing monoclonal protein?
What postural change in FVC is suggestive of respiratory muscle weakness?
What leads you to suspect that a foot drop is secondary to a myopathy rather than a neuropathic process?
What types of cardiac conduction abnormalities would lead you to avoid using tricyclic antidepressants?
How do you counsel patients and doctors on antibiotic avoidance in myasthenia gravis?
In patients with possible Bartonella henselae infection and elevated IgG titer, what is the best way to confirm the diagnosis: tissue biopsy with Warthin-Starry staining, tissue sent for Bartonella henselae PCR, or tissue sent for culture?
When do you use seizure prophylaxis in patients on clozapine?
How do you counsel patients with dermatomyositis on sun protection?
How do you approach use of DMARDs and/or biologics for inflammatory arthritis in patients with a history of seizure disorder on anti-epileptic medications?